|
|
||||||||
Eur J Cardiothorac Surg 2007;32:544-546. doi:10.1016/j.ejcts.2007.05.026
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved
Case reports |
a Department of Cardiac Surgery, Evangelismos Hospital, Athens, Greece
b Hematology Laboratory, Evangelismos Hospital, Athens, Greece
Received 27 February 2007; received in revised form 9 May 2007; accepted 31 May 2007.
* Corresponding author. Address: Doukissis Plakentias 46, Melissia, Athens, Greece. Tel.: +30 6932 71 31 71; fax: +30 210 7224449. (Email: ikouerinis{at}hotmail.com).
| Abstract |
|---|
|
|
|---|
Key Words: Heparin-induced thrombocytopenia Thromboelastography CPB complications ELISA
| 1. Introduction |
|---|
|
|
|---|
Despite the progress in the detection of anti-heparin antibodies, no test can predict which of those HIT patients will present with thrombotic or hemorrhagic complications of HIT type II [1,2].
Several authors have studied the role of thromboelastography (TEG) to evaluate the effect of platelets and rFVIIa on the kinetics of clot formation and clot firmness [3–5]. Our purpose was to explore the potency of TEG to predict those HIT patients (5%) who are subject to develop thrombotic complications of type II. To the best of our knowledge, this is the first report that investigates the role of TEG in HIT subjects.
| 2. Case report |
|---|
|
|
|---|
During the fourth postoperative day, she presented cyanosis at six fingernail phalanxes on both hands despite her perfect hemodynamic condition and the complete lack of vasoconstriction or any other inotropic support.
This striking clinical feature was combined with the significant platelet count reduction (78,000/µl), which was observed from the first postoperative day; so, the most probable diagnosis was heparin-induced thrombocytopenia with thrombosis (HIT type II). As a result, all forms of heparin and coumarin therapy were discontinued.
Despite our strong clinical suspicion for HIT type II; we did not decide to start therapy with a direct thrombin inhibitor due to her high probability for intestinal bleeding. Moreover, the results of ELISA concerning the detection of anti-heparin antibodies in the serum were negative on two occasions.
The significant clinical improvement of the patient's condition during the next 3 days in concordance with the rise in platelet count to 131,000/µl justified initially our watchful waiting policy.
However, an accidental catheter flush with heparin on the eighth postoperative day perpetuated the syndrome and the patient showed acute respiratory distress and sharp deterioration of her peripheral cyanosis with extensive skin blistering and signs of gangrene (Fig. 1 ). As the situation had dramatically worsened, the administration of lepirudin was completely indicated.
|
= 81.2°, MA = 74.5 mm, G
= 14.6 dyn/s (k), CI = 6.1, LY30 = 5.7%), confirming the strong thrombotic diathesis of our HIT patient. Nevertheless, the established signs of gangrene were never reversed, despite the partial improvement observed in the borders of vital-cyanotic zones. A rectal bleeding on the ninth postoperative day was clinically insignificant and the patient was discharged 4 days later with the suggestion of scheduled amputations.
| 3. Discussion |
|---|
|
|
|---|
Nevertheless, it has not been clarified which of those post-cardiac-surgery patients diagnosed for HIT are subject to manifest the thrombotic or hemorrhagic complications of type II. Such a selection would be very helpful and would allow us to start an early and aggressive treatment, which aims at eliminating morbidity and mortality. Although there is an obvious trend in hematology to interpret qualitatively and quantitatively complicated coagulation profiles with additional methods [4,5,7,8], their exact role in HIT has not been investigated yet.
According to our report, the role of TEG can prove to be of great significance at this special point (Fig. 2a and b) [9]. Any HIT patient with abnormal TEG parameters should be considered for further evaluation and proper treatment before the establishment of irreversible thrombotic complications [10]. In our case, the interpretation of TEG results revealed platelet and enzymatic hypercoagulability demanding aggressive treatment with a direct thrombin inhibitor (Fig. 2c and d).
|
In conclusion, TEG can help the cardiac surgeon predict which HIT patients may suffer type II complications of HIT and buy some precious time by starting early, aggressive treatment from the onset of thrombocytopenia, before the establishment of potentially fatal thrombotic and hemorrhagic complications.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
I. A. Kouerinis, A. Kourtesis, M. El-Ali, T. Sergentanis, A. Plagou, M. Argiriou, N. Theakos, and A. Giannakopoulou Heparin induced thrombocytopenia diagnosis in cardiac surgery: is there a role for thromboelastography? Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 560 - 563. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |